United Therapeutics (UTHR) Current Assets (2016 - 2025)
Historic Current Assets for United Therapeutics (UTHR) over the last 17 years, with Q3 2025 value amounting to $3.5 billion.
- United Therapeutics' Current Assets fell 1265.87% to $3.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 billion, marking a year-over-year decrease of 1265.87%. This contributed to the annual value of $3.9 billion for FY2024, which is 909.32% up from last year.
- Per United Therapeutics' latest filing, its Current Assets stood at $3.5 billion for Q3 2025, which was down 1265.87% from $3.8 billion recorded in Q2 2025.
- In the past 5 years, United Therapeutics' Current Assets ranged from a high of $4.0 billion in Q3 2024 and a low of $2.0 billion during Q1 2021
- Its 5-year average for Current Assets is $3.2 billion, with a median of $3.2 billion in 2024.
- In the last 5 years, United Therapeutics' Current Assets skyrocketed by 4547.68% in 2022 and then tumbled by 1265.87% in 2025.
- Quarter analysis of 5 years shows United Therapeutics' Current Assets stood at $2.3 billion in 2021, then skyrocketed by 45.48% to $3.4 billion in 2022, then increased by 5.05% to $3.6 billion in 2023, then grew by 9.09% to $3.9 billion in 2024, then fell by 9.81% to $3.5 billion in 2025.
- Its last three reported values are $3.5 billion in Q3 2025, $3.8 billion for Q2 2025, and $3.9 billion during Q1 2025.